Pharmaceutical Executive December 10, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Resources and Education for Operationalizing Bispecifics

Panelists discuss how infrastructure including specialized staff training, updated protocols, enhanced monitoring systems, and comprehensive educational resources for health care providers is essential for institutions to successfully implement and optimize bispecific antibody therapies while ensuring patient safety and treatment efficacy.

Musk Flexes Muscle to Stop Infowars’ X Account Sale to The Onion

A clash among lawyers from Elon Musk’s X Corp., Alex Jones’ Infowars, and The Onion would normally be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
How will CMS administer the IRA Medicare Drug Price Negotiation under Trump?
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
One Institution’s Evidence-Based Approach to Adopting Biosimilars

Share This Article